Japan, Aug. 6 -- JCR PHARMACEUTICALS CO LTD has got intellectual property rights for 'ANTI-HUMAN TRANSFERRIN RECEPTOR ANTIBODY PERMEATING BLOOD-BRAIN BARRIER.' Other related details are as follows:
Application Number: JP,2025-107169
Category (FI): C07K16/28
Stage: Grant (IP right granted following substantive examination.)
Filing Date: June 25, 2025
Publication Date: Sept. 17, 2025
The original document can be viewed at: https://www.j-platpat.inpit.go.jp/p0100
Disclaimer: Curated by HT Syndication....